Milan, Italy

Ernesto Oppico

This inventor holds 1 USPTO granted patent. Top assignee: Farmitalia Carlo Erba. Active years: 1989.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 1989

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Ernesto Oppico

Introduction

Ernesto Oppico is a notable inventor based in Milan, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the purification of anthracyclinone glycosides. His innovative approach has the potential to enhance the efficiency of drug production processes.

Latest Patents

Oppico holds a patent for a process titled "Process for purifying anthracyclinone glycosides by selective adsorption." This patent describes a method for purifying an impure anthracyclinone glycoside through the selective adsorption of a slightly acidic aqueous solution on at least one resin. The process is followed by the de-absorption of the purified glycoside using acidic water or a mixture of water and a polar solvent. This innovation is crucial for improving the quality of pharmaceutical products.

Career Highlights

Ernesto Oppico is associated with Farmitalia Carlo Erba, a prominent company in the pharmaceutical industry. His work at this organization has allowed him to focus on research and development, contributing to advancements in drug formulation and purification techniques. His expertise in this area has positioned him as a valuable asset to his team.

Collaborations

Oppico has collaborated with notable colleagues such as Carlo Varesio and Onorino G Rosa. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas within the pharmaceutical sector.

Conclusion

Ernesto Oppico's contributions to the field of pharmaceuticals through his innovative patent and collaborative efforts highlight his importance as an inventor. His work continues to influence the industry, paving the way for advancements in drug purification processes.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…